中东和非洲合成生物学市场规模、份额和范围（2028 年）

MEA 合成生物学市场预计将从 698.02 美元增长 2021 年 100 万美元，到 2028 年将达到 2,407.31 亿美元；预计 2021 年至 2028 年复合年增长率为 19.3%。

CRISPR 取得了重大进展基于的技术。此外，领先的合成生物学公司的大量资金和投资继续推动合成生物学产品的主要应用从纺织行业向制药行业的转变。例如，基于 CRISPR 治疗遗传性疾病的首次临床试验的提案已提交给监管机构，重点是针对 β 地中海贫血和镰状细胞病的基因编辑疗法。基于 CRISPR 的基因治疗最有吸引力的目标是由突变引起的遗传疾病。合成生物学领域的另一个趋势是由 Bolt Threads 引领的，该公司已经用蜘蛛丝制造了第一件服装，并且可以在市场上买到。这种丝绸是通过基因编辑技术生产的。此外，据 Twist Bioscience 新闻报道，Spiber 公司与 The North Face 合作生产了一款派克大衣，这是一种由人造蜘蛛丝制成的外套。该公司尚未开始销售这件外套，因为它还没有计算出这件外套的成本。技术和产品的进步正在催生合成生物学市场的新趋势，这可能会推动未来几年的市场增长。

借助新功能和技术，供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能

推动MEA合成生物学市场。 MEA 合成生物学市场预计在预测期内将以显着的复合年增长率增长。

MEA合成生物市场收入及2028年预测（百万美元）

MEA合成生物市场细分

< /p>

MEA 合成生物学市场根据产品、技术、应用和国家进行分析。根据产品，市场分为酶、底盘生物、寡核苷酸和异种核酸。寡核苷酸领域在 2020 年占据市场主导地位，预计在预测期内增长最快。根据技术，市场分为测量和测量。建模、克隆和测序、基因组工程、基因合成、纳米技术等。基因合成领域在 2020 年占据市场主导地位，而基因组工程领域预计在预测期内增长最快。根据应用，市场分为医疗应用、工业应用、食品和农业、环境应用等。医疗应用领域在 2020 年占据市场主导地位，预计在预测期内增长最快。 MEA 合成生物学市场分为沙特阿拉伯、阿联酋、南非和 MEA 的其他地区。

安捷伦科技公司；阿米里斯；法典；金斯瑞生物科技公司；综合 DNA 技术；默克公司；新英格兰生物实验室；诺维信公司；赛默飞世尔科技；和 Twist Bioscience 是 MEA 合成生物学市场的领先公司之一。

Middle East and Africa Synthetic Biology Strategic Insights

Strategic insights for Middle East and Africa Synthetic Biology involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/middle-east-and-africa-synthetic-biology-market-strategic-framework.webp

Get more information on this report

Middle East and Africa Synthetic Biology Report Scope

Report Attribute	Details
Market size in 2021	US$ 698.02 Million
Market Size by 2028	US$ 2,407.31 Million
Global CAGR (2021 - 2028)	19.3%
Historical Data	2019-2020
Forecast period	2022-2028
Segments Covered	By 产品 é¶ åºççç© å¯¡æ ¸è·é¸ å¼ç§æ ¸é¸ By 技术 æµéä¸å»ºæ¨¡ åéä¸æµåº åºå ç»å·¥ç¨ åºå åæ çº³ç±³ææ¯ By 应用 å»çåºç¨ å·¥ä¸åºç¨ é£åååä¸ ç¯å¢åºç¨
Regions and Countries Covered	中东和非洲南非沙特阿拉伯阿联酋中东和非洲其他地区
Market leaders and key company profiles	Agilent Technologies, Inc. Amyris Codexis Genscript Biotech corporation Integrated DNA Technologies Merck KGaA New England Biolabs Novozymes A/S Thermo Fisher Scientific Twist Bioscience

Get more information on this report

Middle East and Africa Synthetic Biology Regional Insights

The regional scope of Middle East and Africa Synthetic Biology refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.